Latest News from EMD

Weather, waning immunity, and human behavior are contributing to an explosive outbreak of dengue that has evolved in the last year, says Dr. Albert Ko, a professor of epidemiology at YSPH who has worked with dengue patients in Brazil for 30 years.

The Yale School of Public health joins the Common Health Coalition with over 50 health organizations dedicated to strengthening public health and health care collaborations.

Using lessons learned from the COVID-19 pandemic, coalition members are working together to identify, amplify, and replicate innovations from across the country to address a resurgence in infectious diseases, chronic diseases, and the overdose crisis.

As Sudan’s humanitarian crisis grows more dire, concerns are growing that foreign actors with interests in Sudan are complicating the situation and making it harder to end a 14-month war that has driven millions from their homes and has put parts of the country on the brink of famine.

Long COVID has always been alarming, but there’s growing concern about its possible relationship to cancer. An expert at Yale’s School of Medicine explains the factors that could cause COVID to increase someone’s cancer risk.

This Spotlight on Teaching shines on Luke Davis, MD, associate professor of epidemiology (microbial diseases) and of medicine (pulmonary), and his focus on implementation science.

A year of civil war between paramilitary Rapid Support Forces and the government has displaced millions of Sudanese, the United Nations says. Much of the violence is taking place in the long-suffering Darfur region - where ordinary people are paying the price. Nathaniel Raymond, director of the Yale School of Public Health's Humanitarian Research Lab, is interviewed for this report.

A civil war is ripping apart Sudan, one of Africa’s largest countries. Yale's Humanitarian Research Lab is monitoring the situation closely.

Solve President and CEO Emily Taylor, Chief Scientific Officer H. Timothy Hsiao, and Director of Advancement Ilise Friedman recently visited Yale School of Medicine’s Center for Infection & Immunity (CII), the Center Director, Sterling Professor Akiko Iwasaki, and her research team, as coordinated by Dr. Nicole Darricarrère, CII’s Scientific Program Director, in New Haven, CT. The Solve delegation honored Professor Iwasaki with an award to recognize her contributions to the study of infection-associated chronic conditions and illnesses, and delivered an invited talk to the Iwasaki Lab to elaborate the power of the Solve Together Real-World Platform to accelerate biomedical research for post-acute infection syndromes, such as ME/CFS and Long Covid.